Company / FCF Margin
Caris Life Sciences, Inc. FCF Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
8.2%
FY2025
5-year range
-97.5% / 8.2%
FY2023-FY2025
Trend
+113.4%
vs FY2024
Sector context
#68 of 144
Health Care
What the data says
At 8.2%, Caris Life Sciences, Inc.'s fcf margin ranks #68 of 144 in the Health Care sector. Improved from -97.5% to 8.2% over the past 2 years.
Based on SEC 10-K filings.
8.2% in FY2025.
Improved from -97.5% to 8.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#68 of 144 in Health CareTop 47% of 144This company 8.2% Sector average -209.0%
▼
+103.9% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 113.4% year-over-year.
- Currently 217.3pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.2% | +113.4% |
| FY2024 | -61.5% | +36.9% |
| FY2023 | -97.5% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026